Related Experiment Video
Updated: Feb 8, 2026
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2
Zheng-Qing Fang1, Mao-Chun Li2, Yu-Qin Zhang3
1School of Nursing, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Abstract:
We intended to evaluate miR-490-5p expression in hepatocellular carcinoma (HCC) tissues and detect the potential targets of miR-490-5p. In vitro experiments were conducted to further investigate the biological function of miR-490-5p on HCC cell metastasis. We investigated the abnormally expressed miRNAs in HCC tissues, and the miR-490-5p expression level was detected by qRT-PCR. E2F2 and ECT2 were proved to be the potential targets of miR-490-5p by luciferase reporter assay. The expression levels of E2F2 and ECT2 were determined using Western blot. Transwell assay was used to analyse the impact of miR-490-5p on metastasis of HCC cells. Four high-expressed miRNAs, and seven low-expressed miRNAs, including miR-490-5p, were detected in HCC tissues. The expression level of miR-490-5p was connected with the tumor size, tumor node metastasis (TNM) stage, and survival ratio of HCC patients. E2F2 and ECT2 were the targets of miR-490-5p, and miR-490-5p inhibited HCC cell metastasis through down-regulating the expressions of E2F2 and ECT2. The over-expressed miR-490-5p could restrain the metastasis of HCC cells by down-regulating E2F2 and ECT2 expression levels.
Insights
MicroRNA-490-5p is downregulated in hepatocellular carcinoma (HCC) and inhibits cancer metastasis by targeting E2F2 and ECT2. This finding offers a potential therapeutic strategy for HCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Aberrant microRNA (miRNA) expression is implicated in HCC development and progression.
- Understanding specific miRNA roles is crucial for targeted therapies.
Purpose of the Study:
- To investigate the expression of miR-490-5p in HCC tissues.
- To identify potential target genes of miR-490-5p.
- To elucidate the role of miR-490-5p in HCC cell metastasis.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for miRNA expression analysis.
- Luciferase reporter assay to validate miRNA-target interactions.
- Western blot to assess protein expression levels.
- Transwell assays to evaluate cell metastasis.
Main Results:
- miR-490-5p was found to be downregulated in HCC tissues.
- E2F2 and ECT2 were confirmed as direct targets of miR-490-5p.
- Downregulation of miR-490-5p correlated with tumor size, TNM stage, and poorer survival.
- Overexpression of miR-490-5p significantly inhibited HCC cell metastasis by reducing E2F2 and ECT2 expression.
Conclusions:
- miR-490-5p acts as a tumor suppressor in HCC.
- miR-490-5p inhibits HCC cell metastasis through the downregulation of E2F2 and ECT2.
- miR-490-5p represents a potential biomarker and therapeutic target for HCC.
Related Concept Videos
00:46Feedback Inhibition
01:46Epigenetic Regulation
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:23Master Transcription Regulators
01:23Negative Regulator Molecules
02:24Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...